Naia Pharmaceuticals Overview
- Founded
-
2014

- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
Naia Pharmaceuticals General Information
Description
Operator of a biopharmaceutical company created to develop drugs for Short Bowel Syndrome. The company develops clinically advance drug candidates for Short Bowel Syndrome (SBS) and other rare gastrointestinal diseases enabling health care providers to treat gastrointestinal problems and disorders and reduce recovery times.
Contact Information
Website
www.naiapharma.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
- 2600 Hilltop Drive
- Richmond, CA 94806
- United States
Naia Pharmaceuticals Valuation & Funding
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
Naia Pharmaceuticals Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Operator of a biopharmaceutical company created to develop drugs for Short Bowel Syndrome. The company develops clinical
Pharmaceuticals
Richmond, CA
00.00
0.00
0000-00-00
000000&0
00.00
Naia Pharmaceuticals Competitors (6)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Botanix Pharmaceuticals | Corporation | Perth, Australia | 0 | 000.00 | 000000000 | 000.00 |
00000000 000000000 | Corporation | Melbourne, Australia | 00 | 000000&0 | ||
0000000 | Corporation | Solna, Sweden | 0 | |||
0000000 0000000000 | Private Equity-Backed | Pune, India | 000 | 000.00 | 000000000 | 000.00 |
0000000 0000000000 | Formerly VC-backed | Westlake Village, CA | 000 | 00000 | 000000000 | 00000 |
Naia Pharmaceuticals Former Investors
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|